Abiopharma

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

Sonida Senior Living Announces $900 Million of Permanent Debt Financing Commitments in Connection with CNL Healthcare Properties, Inc. Strategic Merger

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)

Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

CoyaTherapeutics - Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Frontotemporal Dementia (FTD)

Novo Nordisks Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America

Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules